08:24 AM EDT, 07/14/2025 (MT Newswires) -- ImmunoPrecise Antibodies ( IPA ) said Monday that it has regained compliance with a minimum bid price requirement to trade on the Nasdaq stock market.

For 10 consecutive trading days between June 26 to July 10, the closing bid price of the company's shares was at or above $1 per share, satisfying the requirements for continued listing on the exchange.

Shares were over 3% higher in recent premarket activity.